Presidio Partners 2007 GP, LLC, 10% Owner at Neos Therapeutics, Inc. (NEOS), sold 35,791 shares at $10.03 ($357K) on 2016-04-19, disclosed to the SEC on 2016-04-20.
Open-market sale of $357k NEOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.10 | 114 | $1K | 0.3% |
| 2 | $10.10 | 4,434 | $45K | 12.6% |
| 3 | $10.03 | 182 | $2K | 0.5% |
| 4 | $10.03 | 7,097 | $71K | 20.0% |
| 5 | $10.03 | 7,097 | $71K | 20.0% |
| 6 | $9.88 | 213 |
| $2K |
| 0.6% |
| 7 | $9.88 | 8,327 | $82K | 23.1% |
| 8 | $9.88 | 8,327 | $82K | 23.1% |
| Total | $9.97 avg | 35,791 | $357K | 100% |